These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 671271)

  • 1. Scatchard plots with a positive slope and role of albumin concentration.
    Bowmer CJ; Lindup WE
    J Pharm Sci; 1978 Aug; 67(8):1193-5. PubMed ID: 671271
    [No Abstract]   [Full Text] [Related]  

  • 2. Variation in the heats of reaction of drugs and albumin with the source and pretreatment of the albumin.
    Hardee GE; Otagiri M; Perrin JH
    J Pharm Pharmacol; 1979 Sep; 31(9):656. PubMed ID: 41083
    [No Abstract]   [Full Text] [Related]  

  • 3. Dependence of drug-protein binding parameters on human serum and albumin concentration.
    Brunner F; Zini R; Tillement JP
    J Pharm Pharmacol; 1983 Aug; 35(8):526-8. PubMed ID: 6137542
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vitro model of drug-albumin interaction [proceedings].
    McElnay JC; Arcy PF
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():1P. PubMed ID: 22637
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of protein binding by ultracentrifugation.
    Matsushita Y; Moriguchi I
    Chem Pharm Bull (Tokyo); 1985 Jul; 33(7):2948-55. PubMed ID: 4085054
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of increasing albumin concentrations on the determination of the binding of sulfamethoxy-pyridazine to human and bovine serum albumin.
    Miese H; Müller WE; Wollert U
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):18-26. PubMed ID: 570826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug binding defect of uraemic plasma: unlikely involvement of carbamoylated albumin.
    Clegg LS; Lindup WE
    Biochem Pharmacol; 1982 Sep; 31(17):2791-4. PubMed ID: 7138574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scatchard plots with a positive slope: dependence upon ligand concentration.
    Clegg LS; Lindup WE
    J Pharm Pharmacol; 1984 Nov; 36(11):776-9. PubMed ID: 6150986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin--a non-saturable carrier.
    Brodersen R; Honoré B; Larsen FG
    Acta Pharmacol Toxicol (Copenh); 1984 Feb; 54(2):129-33. PubMed ID: 6711320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcalorimetric investigations of pharmaceutical complexes II. Drug-albumin interactions.
    Otagiri M; Hardee GE; Perrin JH
    Biochem Pharmacol; 1978 May; 27(9):1401-4. PubMed ID: 697945
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors affecting drug-protein binding in the plasma of newborn infants.
    Wallace S
    Br J Clin Pharmacol; 1976 Jun; 3(3):510-2. PubMed ID: 973977
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct and indirect determination of binding constants of drug-protein complexes with microparticles.
    Kober A; Ekman B; Sjöholm I
    J Pharm Sci; 1978 Jan; 67(1):107-9. PubMed ID: 619095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New fluorescence probes for drug-albumin interaction studies.
    Goya S; Takadate A; Fujino H; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1363-9. PubMed ID: 7105256
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug binding in human serum albumin as assayed by diafiltration and fluorimetry.
    Geddes R; White PM
    Biochem Pharmacol; 1979 Aug; 28(15):2285-8. PubMed ID: 497010
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 17. The classification of drugs on the basis of the drug-binding site on human serum albumin.
    Iwatsuru M; Nishigori H; Maruyama K
    Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4489-93. PubMed ID: 7168873
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of free fatty acid concentration on drug binding to plasma albumin.
    Spector AA; Santos EC; Ashbrook JD; Fletcher JE
    Ann N Y Acad Sci; 1973 Nov; 226():247-58. PubMed ID: 4520396
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of fatty acids on two specific drug binding sites on human serum albumin.
    Birkett DJ; Myers SP; Sudlow G
    Mol Pharmacol; 1977 Nov; 13(6):987-92. PubMed ID: 593269
    [No Abstract]   [Full Text] [Related]  

  • 20. The location of drug binding sites in human serum albumin.
    Fehske KJ; Müller WE; Wollert U
    Biochem Pharmacol; 1981 Apr; 30(7):687-92. PubMed ID: 7018498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.